These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4830977)

  • 21. [Investigation of the absorption of orally administered chloramphenicol preparations].
    Finholt P; Lunde PK; Midtvedt T; Aarnes ED
    Tidsskr Nor Laegeforen; 1971 Jun; 91(16):1245-6. PubMed ID: 5565809
    [No Abstract]   [Full Text] [Related]  

  • 22. [Serum levels of chloramphenicol during simultaneous administration of penicillin in children].
    Windorfer A
    Z Kinderheilkd; 1972; 112(1):79-88. PubMed ID: 5019027
    [No Abstract]   [Full Text] [Related]  

  • 23. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Determination of residues of chloramphenicol in rainbow trout (Salmo gairdneri) and Atlantic salmon (Salmo salar) (author's transl)].
    Skåre JU; Håstein T; Froslie A
    Nord Vet Med; 1974 Feb; 26(2):108-15. PubMed ID: 4840814
    [No Abstract]   [Full Text] [Related]  

  • 25. Plasma concentrations of chloramphenicol in snakes.
    Clark CH; Rogers ED; Milton JL
    Am J Vet Res; 1985 Dec; 46(12):2654-7. PubMed ID: 4083608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Kinetics of chloramphenicol succinate in parenteral administration].
    Havelka J; Mertenová J; Procházka J
    Cas Lek Cesk; 1968 Oct; 107(42):1268-72. PubMed ID: 5681916
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bioavailability of levomycetin preparations for oral use].
    Batuashvili TA; Zak AF
    Antibiotiki; 1983 Oct; 28(10):751-4. PubMed ID: 6651263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma chloramphenicol concentrations in the dog after the parenteral administration of chloramphenicol sodium succinate.
    Pauli JV; English PB
    J Small Anim Pract; 1971 Nov; 12(11):643-8. PubMed ID: 5139283
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum chloramphenicol concentrations in preruminant calves: a comparison of two formulations dosed orally.
    Huffman EM; Clark CH; Olson JD; Ball L
    J Vet Pharmacol Ther; 1981 Sep; 4(3):225-31. PubMed ID: 7349338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance.
    Glaze ER; Lambert AL; Smith AC; Page JG; Johnson WD; McCormick DL; Brown AP; Levine BS; Covey JM; Egorin MJ; Eiseman JL; Holleran JL; Sausville EA; Tomaszewski JE
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):637-47. PubMed ID: 15986212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absorption and dissolution characteristics of 14 different oral chloramphenicol preparations tested on healthy human male subjects.
    Bel H; Johansen H; Lunde PK; Andersgaard HA; Finholt P; Midtvedt T; Holum E; Martinussen B; Aarnes ED
    Pharmacology; 1971; 5(2):108-20. PubMed ID: 5570924
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advocates lower chloramphenicol dosage.
    Watson AD
    J Am Vet Med Assoc; 1980 Nov; 177(10):980, 982. PubMed ID: 7462085
    [No Abstract]   [Full Text] [Related]  

  • 34. Subchronic oral toxicity of ubiquinol in rats and dogs.
    Kitano M; Watanabe D; Oda S; Kubo H; Kishida H; Fujii K; Kitahara M; Hosoe K
    Int J Toxicol; 2008; 27(2):189-215. PubMed ID: 18404543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Penetration of chloramphenicol into the agueous humours and cerebrospinal fluid after oral administration in horses].
    Zakopal J; Hanák J; Kottman J
    Zentralbl Veterinarmed A; 1970 Jun; 17(6):558-64. PubMed ID: 4988388
    [No Abstract]   [Full Text] [Related]  

  • 36. [Oral administration of chloramphenicol in ruminants. Useless form of treatment (author's transl)].
    de Corte-Baeten K
    Tijdschr Diergeneeskd; 1977 Feb; 102(4):274-5. PubMed ID: 835134
    [No Abstract]   [Full Text] [Related]  

  • 37. [Influence of dosage form on drug effect].
    Zathurecký L
    Pharmazie; 1972 Nov; 27(11):686-93. PubMed ID: 4650983
    [No Abstract]   [Full Text] [Related]  

  • 38. Absorption of chloramphenicol by various routes of administration.
    Shah PN; D'Souza J; Dattani KK
    Indian J Med Res; 1977 Apr; 65(4):549-53. PubMed ID: 908607
    [No Abstract]   [Full Text] [Related]  

  • 39. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
    Han J; Shin HC; Kim JC; Kim B
    Food Chem Toxicol; 2004 Mar; 42(3):373-80. PubMed ID: 14871579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.